Sava’s mission is to build the technological foundation for preventative and personalised healthcare. The team has developed the world’s first multi-molecule biosensor, powered by proprietary microsensing technology. Their first product – a pain-free, affordable Continuous Glucose Monitor – has delivered strong results in early clinical trials, achieving up to 10 days of accurate, real-time glucose monitoring in people with diabetes.